TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ANAB

AnaptysBio Inc

Healthcare · Biotechnology

53.90$ -1.8% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

AnaptysBio Inc (ANAB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 364 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANAB
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
25 56 62 329 509 435 417 643 610 452 484 364
24 53 58 253 434 378 397 554 447 407 432 350
22 52 51 81 114 171 250 496 71 36 123 238
22 52 51 248 427 374 394 548 441 391 385 312
1.5 1.2 5.3 1.6 0.2 0.0 0.9 1.4 6.9 41 34
0.0 0.0 0.0 0.0 0.0
0.6 0.6 0.5 0.7 1.4 3.0 1.8 2.3 2.1
0.0
0.0
19 14 23 22 23 30 20 287 348 364 413 327
12 7.4 5.7 14 22 30 20 16 26 37 45 39
0.1 0.0 0.0 6.9 7.6 2.2 0.3 1.5 1.6 1.8 1.9 2.1
0.4 1.5 2.3 2.3 5.4 16 4.2 1.7 2.8 4.7 4.0 3.9
4.8 4.9 14 7.6 0.6
6.0 42 39 308 486 405 397 356 262 88 71 37
-45 -51 -55 -85 -147 -244 -264 -322 -450 -614 -759 -773
2.5 2.6 2.6 20 25 27 27 27 28 27 28 31

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?